Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Pediatr ; 166(3): 679-83.e2, 2015 Mar.
Article de Anglais | MEDLINE | ID: mdl-25722271

RÉSUMÉ

OBJECTIVE: To determine whether clinicians could reliably predict health-related quality of life (HRQOL) for children with cardiac disease, the level of agreement in predicted HRQOL scores between clinician sub-types, and agreement between clinician-predicted HRQOL scores and patient and parent-proxy reported HRQOL scores. STUDY DESIGN: In this multicenter, cross-sectional study, a random sample of clinical summaries of children with cardiac disease and related patient and parent-proxy reported HRQOL scores were extracted from the Pediatric Cardiac Quality of Life Inventory data registry. We asked clinicians to review each clinical summary and predict HRQOL. RESULTS: Experienced pediatric cardiac clinicians (n = 140), including intensive care physicians, outpatient cardiologists, and intensive care, outpatient, and advanced practice nurses, each predicted HRQOL for the same 21 pediatric cardiac patients. Reliability within clinician subspecialty groups for predicting HRQOL was poor (intraclass correlation coefficients, 0.34-0.38). Agreement between clinician groups was low (Pearson correlation coefficients, 0.10-0.29). When comparing the average clinician predicted HRQOL scores to those reported by patients and parent-proxies by Bland Altman plots, little systematic bias was present, but substantial variability existed. Proportional bias was found, in that clinicians tended to overestimate HRQOL for those patients and parent-proxies who reported lower HRQOL, and underestimate HRQOL for those reporting higher HRQOL. CONCLUSIONS: Clinicians perform poorly when asked to predict HRQOL for children with cardiac disease. Clinicians should be cognizant of these data when providing counseling. Incorporating reported HRQOL into clinical assessment may help guide individualized treatment decision-making.


Sujet(s)
Cardiopathies/psychologie , Mandataire/psychologie , Qualité de vie , Adolescent , Enfant , Études transversales , Femelle , Humains , Mâle , Reproductibilité des résultats , Enquêtes et questionnaires
2.
J Pediatr ; 158(4): 638-643.e1, 2011 Apr.
Article de Anglais | MEDLINE | ID: mdl-21195415

RÉSUMÉ

OBJECTIVE: To investigate factors associated with mechanical circulatory support and survival in patients with acute fulminant myocarditis (AFM). STUDY DESIGN: Retrospective cohort of AFM patients admitted to the cardiac intensive care unit during 1996-2008. AFM was defined as distinct onset of symptoms ≤14 days before admission, rapid-onset cardiogenic shock, and normal left ventricular size. Demographic and physiological variables were compared between patients treated with extracorporeal membrane oxygenation (ECMO) and those who were not and between survivors and nonsurvivors. RESULTS: Twenty patients (median age 12.7 years) met inclusion criteria. Seventeen patients (85%) survived to hospital discharge. One underwent heart transplantation. Ten (50%) patients required ECMO, and 7 (70%) of these survived. On admission, patients requiring ECMO had elevated lactate (9 vs 1 mmol/L), creatinine (0.8 vs 0.6 mg/dL), and aspartate aminotransferase (256 vs 35 IU/L) (all P < .05) and a trend towards increased incidence of dysrhythmias (80% vs 30%, P = .07). During hospitalization, non-survivors had higher peak lactate (10 vs 3 mmol/L), creatinine (1.5 vs 0.8 mg/dL), and aspartate aminotransferase (3007 vs 156 IU/L) (all P < .05) compared with survivors. CONCLUSIONS: Patients with AFM with end organ dysfunction or arrhythmias on admission may require mechanical circulatory support. The transplant-free survival rate in this critically ill cohort was excellent (80%).


Sujet(s)
Myocardite/mortalité , Myocardite/thérapie , Maladie aigüe , Adolescent , Aspartate aminotransferases/sang , Enfant , Enfant d'âge préscolaire , Créatinine/sang , Oxygénation extracorporelle sur oxygénateur à membrane , Femelle , Transplantation cardiaque/statistiques et données numériques , Dispositifs d'assistance circulatoire , Humains , Immunoglobulines par voie veineuse/usage thérapeutique , Facteurs immunologiques/usage thérapeutique , Nourrisson , Nouveau-né , Acide lactique/sang , Mâle , Myocardite/diagnostic , Myocardite/anatomopathologie , Myocardite/physiopathologie , Myocarde/anatomopathologie , Études rétrospectives , Analyse de survie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE